Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Vigneri

Showing results (81-90 of 150) with videos related to

Pageof 15
Sort By:
Cancer Treatment Reviews|August 25, 2024
Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implicationsFrancesco Schettini, Federica Gattazzo, Sabrina Nucera, et al.
American Journal of Clinical Oncology|January 22, 2021
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and SafetyMaria R Valerio, Eugenia Arrivas Bajardi, Carmelo C Arcara, et al.
Frontiers in Neurology|February 28, 2022
Glioblastoma, <i>IDH</i>-Wild Type With <i>FGFR3-TACC3</i> Fusion: When Morphology May Reliably Predict the Molecular Profile of a Tumor. A Case Report and Literature ReviewGiuseppe Broggi, Eliana Piombino, Roberto Altieri, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
A Case of Non-Irradiated Balloon Cell Melanoma of the Choroid: Expanding the Morphological Spectrum of Primary Uveal MelanomasMaria Failla, Rosario Caltabiano, Antonio Longo, et al.
Current Oncology (Toronto, Ont.)|May 24, 2024
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi ApproachDario Piazza, Federica Martorana, Annabella Curaba, et al.
International Journal of Molecular Sciences|January 9, 2021
Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic SyndromesStefania Stella, Michele Massimino, Livia Manzella, et al.
Oncotargets and Therapy|October 9, 2023
High <i>BCR::ABL1</i> Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal AbilityMichele Massimino, Stefania Stella, Elena Tirrò, et al.
American Journal of Clinical Oncology|May 19, 2025
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast CancerFederica Martorana, Maria V Sanò, Alessandra Fabi, et al.
Case Reports in Oncological Medicine|March 17, 2021
Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two CasesFederica Martorana, Katia Lanzafame, Giuliana Pavone, et al.
Operative Neurosurgery (Hagerstown, Md.)|October 9, 2020
FLAIRectomy in Supramarginal Resection of Glioblastoma Correlates With Clinical Outcome and Survival Analysis: A Prospective, Single Institution, Case SeriesFrancesco Certo, Roberto Altieri, Massimiliano Maione, et al.
Pageof 15

Showing results (81-90 of 150) with videos related to

Sort By:
Pageof 15
Cancer Treatment Reviews|August 25, 2024
Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implicationsFrancesco Schettini, Federica Gattazzo, Sabrina Nucera, et al.
American Journal of Clinical Oncology|January 22, 2021
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and SafetyMaria R Valerio, Eugenia Arrivas Bajardi, Carmelo C Arcara, et al.
Frontiers in Neurology|February 28, 2022
Glioblastoma, <i>IDH</i>-Wild Type With <i>FGFR3-TACC3</i> Fusion: When Morphology May Reliably Predict the Molecular Profile of a Tumor. A Case Report and Literature ReviewGiuseppe Broggi, Eliana Piombino, Roberto Altieri, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
A Case of Non-Irradiated Balloon Cell Melanoma of the Choroid: Expanding the Morphological Spectrum of Primary Uveal MelanomasMaria Failla, Rosario Caltabiano, Antonio Longo, et al.
Current Oncology (Toronto, Ont.)|May 24, 2024
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi ApproachDario Piazza, Federica Martorana, Annabella Curaba, et al.
International Journal of Molecular Sciences|January 9, 2021
Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic SyndromesStefania Stella, Michele Massimino, Livia Manzella, et al.
Oncotargets and Therapy|October 9, 2023
High <i>BCR::ABL1</i> Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal AbilityMichele Massimino, Stefania Stella, Elena Tirrò, et al.
American Journal of Clinical Oncology|May 19, 2025
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast CancerFederica Martorana, Maria V Sanò, Alessandra Fabi, et al.
Case Reports in Oncological Medicine|March 17, 2021
Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two CasesFederica Martorana, Katia Lanzafame, Giuliana Pavone, et al.
Operative Neurosurgery (Hagerstown, Md.)|October 9, 2020
FLAIRectomy in Supramarginal Resection of Glioblastoma Correlates With Clinical Outcome and Survival Analysis: A Prospective, Single Institution, Case SeriesFrancesco Certo, Roberto Altieri, Massimiliano Maione, et al.
Pageof 15